Not available
Quote | Invitae Corporation (NYSE:NVTA)
Last: | $0.0891 |
---|---|
Change Percent: | -337.71% |
Open: | $0.39 |
Close: | $0.0891 |
High: | $0.3932 |
Low: | $0.081 |
Volume: | 94,199,600 |
Last Trade Date Time: | 02/05/2024 03:00:00 am |
News | Invitae Corporation (NYSE:NVTA)
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Message Board Posts | Invitae Corporation (NYSE:NVTA)
Subject | By | Source | When |
---|---|---|---|
I was absolutely spot on!!! | OptimusPrime555 | investorshub | 03/01/2023 5:02:43 PM |
Pump and dump! ROFLMAO | OptimusPrime555 | investorshub | 08/15/2022 6:31:36 PM |
ARK update | LandToSea | investorshub | 08/15/2022 1:18:43 PM |
What happened here? ROFLMAO | OptimusPrime555 | investorshub | 08/11/2022 3:06:45 PM |
I just did!! Hard to get it DOWN, | Invest-in-America | investorshub | 08/10/2022 10:21:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Thursday, Labcorp (NYSE:LH) reported first-quarter sales increased 4.6% to $3.18 billion, beating the consensus of $3.12 billion. Base Bu...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...